Saso Cemerski,
Senior Director
Saso Cemerski is a Senior Director at Cue Biopharma and leads the company’s Immuno-Oncology Discovery and Translational Immunology team. His focus is on early pipeline development, building preclinical packages for assets in the immuno-oncology pipeline and developing adequate translational biomarker strategies to test key hypotheses in the clinic. Prior to joining Cue Biopharma, Dr. Cemerski held positions at Xencor, BMS and most recently, MSD where he led the STING agonist programs and participated as a core-team member of the anti-LAG-3 program, both of which are currently in the clinic. Dr. Cemerski did his postdoctoral training at Washington University in St Louis, Missouri where he worked to elucidate how immune synapses control T cell activation.
|
|
|
